Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 12-Sep-2018
No. of pages: 107

Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease.

Scope of the Report:

This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Entyvio (vedolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Takeda

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Type 1

- Type 2

Market Segment by Applications, can be divided into

- Ulcerative Colitis

- Crohn's Disease

There are 15 Chapters to deeply display the global Entyvio (vedolizumab) Drug market.

Chapter 1, to describe Entyvio (vedolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Entyvio (vedolizumab) Drug, with sales, revenue, and price of Entyvio (vedolizumab) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Entyvio (vedolizumab) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Entyvio (vedolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Entyvio (vedolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Entyvio (vedolizumab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Type 1
1.2.2 Type 2
1.3 Market Analysis by Applications
1.3.1 Ulcerative Colitis
1.3.2 Crohn's Disease
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Business Overview
2.1.2 Entyvio (vedolizumab) Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Entyvio (vedolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Entyvio (vedolizumab) Drug Market Analysis by Regions
4.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.3 Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.5 South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5 North America Entyvio (vedolizumab) Drug by Countries
5.1 North America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5.3 Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6 Europe Entyvio (vedolizumab) Drug by Countries
6.1 Europe Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.3 UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.4 France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.5 Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.6 Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Entyvio (vedolizumab) Drug by Countries
7.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.3 Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.4 Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.5 India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8 South America Entyvio (vedolizumab) Drug by Countries
8.1 South America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Entyvio (vedolizumab) Drug by Countries
9.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.3 UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
10 Global Entyvio (vedolizumab) Drug Market Segment by Type
10.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Type (2013-2018)
10.2 Type 1 Sales Growth and Price
10.2.1 Global Type 1 Sales Growth (2013-2018)
10.2.2 Global Type 1 Price (2013-2018)
10.3 Type 2 Sales Growth and Price
10.3.1 Global Type 2 Sales Growth (2013-2018)
10.3.2 Global Type 2 Price (2013-2018)
11 Global Entyvio (vedolizumab) Drug Market Segment by Application
11.1 Global Entyvio (vedolizumab) Drug Sales Market Share by Application (2013-2018)
11.2 Ulcerative Colitis Sales Growth (2013-2018)
11.3 Crohn's Disease Sales Growth (2013-2018)
12 Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Entyvio (vedolizumab) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.2 Europe Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.4 South America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.3 Entyvio (vedolizumab) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)
12.4 Entyvio (vedolizumab) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Entyvio (vedolizumab) Drug Picture
Table Product Specifications of Entyvio (vedolizumab) Drug
Figure Global Sales Market Share of Entyvio (vedolizumab) Drug by Types in 2017
Table Entyvio (vedolizumab) Drug Types for Major Manufacturers
Figure Type 1 Picture
Figure Type 2 Picture
Figure Entyvio (vedolizumab) Drug Sales Market Share by Applications in 2017
Figure Ulcerative Colitis Picture
Figure Crohn's Disease Picture
Figure United States Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Entyvio (vedolizumab) Drug Type and Applications
Table Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Entyvio (vedolizumab) Drug Sales by Manufacturer (2016-2017)
Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2016
Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2017
Table Global Entyvio (vedolizumab) Drug Revenue by Manufacturer (2016-2017)
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2016
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Regions (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Market Share by Regions (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue by Regions (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2013
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2017
Figure North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table North America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table North America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2013
Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table North America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013
Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2016
Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries 2017
Table Asia-Pacific Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue Market Share by Countries 2017
Figure China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table South America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table South America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table South America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Share by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue Share by Type (2013-2018)
Figure Global Type 1 Sales Growth (2013-2018)
Figure Global Type 1 Price (2013-2018)
Figure Global Type 2 Sales Growth (2013-2018)
Figure Global Type 2 Price (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Application (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Share by Application (2013-2018)
Figure Global Crohn's Disease Sales Growth (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Regions (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Europe Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure South America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Smart Inhaler Technology Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 117
    The smart inhaler technology uses sensors and requires a smartphone or a computer-based app, which can be integrated into any metered-dose inhaler (MDI) or dry-powder inhaler (DPI) inhaler to convert it into a smart inhaler. The sensors used in smart inhalers can be connected to the user's smartphone or computer to provide information on the dosages, frequency, and medications required by the user. Scope of the Report: This report focuses on the Smart Inhaler Techno......
  • Global IV Bags Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 151
    IV Bag includes flex plastics bag, semi-rigid IV Bags, glass bottles. Scope of the Report: This report focuses on the IV Bags in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The global average price of IV Bags is in the decreasing trend, from 104 USD/K Unit in 2012 to 95 USD/K Unit in 2017. With the s......
  • Global Foam Dressing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 154
    A Foam Dressing, consists of sterile polyurethane foam, hydrocolloid adhesive (polystyrene, sodium carboxymethyl cellulose, etc.), which is an opaque polyurethane dressing that is permeable to vapors but partially occlusive to liquids. It is typically used to cover wounds over bony ridges or near inflamed skin, especially in burns, open wounds, pressure ulcers,venous ulcers, diabetic, etc. Scope of the Report: This report focuses on the Foam Dressing in global marke......
  • Global Medical Implants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 118
    Medical implants are artificial devices or tissues, which are used to replace damaged biological structures or enhance an existing biological structure. Scope of the Report: This report focuses on the Medical Implants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. North America holds a significant sh......
  • Global Silver Dressing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 150
    Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a wound dressing impregnated with ionic silver. The ionic silver is responsible for the anti-microbial activity against infection caused by bacteria. Scope of the Report: This report focuses on the Silver Dressing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This rep......
  • Global PET-CT Scanning Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 120
    Positron emission tomography-computed tomography (PET-CT) is a medical analytical technique used to examine the metabolic activity of tissues. This technique makes the use of PET scanner and an X-ray CT scanner. Scope of the Report: This report focuses on the PET-CT Scanning in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applic......
  • Global Held Pulse Oximeter Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 122
    Held pulse oximeters are non-invasive devices that are attached to the fingertip. These held pulse oximeters monitor the heart rate and measure the oxygen saturation level of a person. Held pulse oximeters are widely used in medical institutes and hospitals. It is more sophisticated when compared with traditional counterparts. In this type of pulse oximeter, the screen is not attached to the clip, but a cable is used to attach the clip to the screen. The screen displays other information related......
  • Global Operating Room Cameras Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 123
    Operating room carmeras is uesd for recording surgery processing and ensure patient safety. This equipment could decrease the errors occuring and montiner the whole people actions in trearment period. Scope of the Report: This report focuses on the Operating Room Cameras in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicatio......
  • Global Healthcare Wipes Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 121
    Healthcare wipes are used to maintain personal hygiene and sanitation, including skin cleansing, surface cleaning, disinfection, hand sanitizing, and hospital sterilization. Most commonly used healthcare wipes are bed bath wipes, macerator friendly body wipes, flushable skin cleansing wipes, pre-injection alcohol wipes, and non-invasive medical device disinfecting wipes, which are available in a wide variety of packaging such as sachets, flow-packs, canisters/tubs, or buckets. Sco......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs